PET-based biomarkers, particularly those using innovative tracers like [68Ga]-PSMA and [18F]-FAPI, achieved the highest sensitivity and specificity, averaging 89.5% and 91.2% across various cancer types [73]. The gene discussed is FOLH1; the disease is cancer.